DNA methylation and histone acetylation contribute to the transcriptional regulation of genes involved in apoptosis. We have demonstrated that docosahexaenoic acid (DHA, 22:6 n-3) and butyrate enhance colonocyte apoptosis. To determine if DHA and/or butyrate elevate apoptosis through epigenetic mechanisms thereby restoring the transcription of apoptosis-related genes, we examined global methylation; gene-specific promoter methylation of 24 apoptosis-related genes; transcription levels of Cideb, Dapk1, and Tnfrsf25; and global histone acetylation in the HCT-116 colon cancer cell line. Cells were treated with combinations of (50 µM) DHA or linoleic acid (18:2 n-6), (5 mM) butyrate or an inhibitor of DNA methyltransferases, and 5-aza-2′-deoxycytidine (5-Aza-dC, 2 µM). Among highly methylated genes, the combination of DHA and butyrate significantly reduced methylation of the proapoptotic Bcl2l11, Cideb, Dapk1, Ltbr, and Tnfrsf25 genes compared to untreated control cells. DHA treatment reduced the methylation of Cideb, Dapk1, and Tnfrsf25. These data suggest that the induction of apoptosis by DHA and butyrate is mediated, in part, through changes in the methylation state of apoptosis-related genes.
BirdA. Perceptions of epigenetics. Nature2007; 447: 396–8.
2.
EstellerM. Epigenetics in cancer. N Engl J Med2008; 358: 1148–59.
3.
IssaJP. CpG island methylator phenotype in cancer. Nat Rev Cancer2004; 4: 988–93.
4.
SamowitzWSAlbertsenHHerrickJLevinTRSweeneyCMurtaughMAWolffRKSlatteryML. Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology2005; 129: 837–45.
5.
WongJJHawkinsNJWardRL. Colorectal cancer: a model for epigenetic tumorigenesis. Gut2007; 56: 140–8.
6.
GopisettyGRamachandranKSingalR. DNA methylation and apoptosis. Mol Immunol2006; 43: 1729–40.
7.
FriedrichMGWeisenbergerDJChengJCChandrasomaSSiegmundKDGonzalgoMLTomaMIHulandHYooCTsaiYCNicholsPWBochnerBHJonesPALiangG. Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients. Clin Cancer Res2004; 10: 7457–65.
8.
ZorkoBAPerezLBDe BlancoEJ. Effects of ILTG on DAPK1 promoter methylation in colon and leukemia cancer cell lines. Anticancer Res2010; 30: 3945–50.
9.
ChangWCChapkinRSLuptonJR. Predictive value of proliferation, differentiation and apoptosis as intermediate markers for colon tumorigenesis. Carcinogenesis1997; 18: 721–30.
10.
DavidsonLANguyenDVHokansonRMCallawayESIsettRBTurnerNDDoughertyERWangNLuptonJRCarrollRJChapkinRS. Chemopreventive n-3 polyunsaturated fatty acids reprogram genetic signatures during colon cancer initiation and progression in the rat. Cancer Res2004; 64: 6797–804.
11.
ChapkinRSHongMYFanYYDavidsonLASandersLMHendersonCEBarhoumiRBurghardtRCTurnerNDLuptonJR. Dietary n-3 PUFA alter colonocyte mitochondrial membrane composition and function. Lipids2002; 37: 193–9.
12.
DavieJR. Inhibition of histone deacetylase activity by butyrate. J Nutr2003; 133: 2485 S–93 S.
13.
ChoYKimHTurnerNDMannJCWeiJTaddeoSSDavidsonLAWangNVannucciMCarrollRJChapkinRSLuptonJR. A chemoprotective fish oil- and pectin-containing diet temporally alters gene expression profiles in exfoliated rat colonocytes throughout oncogenesis. J Nutr2011; 141: 1029–35.
14.
ChoYTurnerNDDavidsonLAChapkinRSCarrollRJLuptonJR. A chemoprotective fish oil/pectin diet enhances apoptosis via Bcl-2 promoter methylation in rat azoxymethane-induced carcinomas. Exp Biol Med (Maywood)2012; 237: 1387–93.
15.
BenderCMPaoMMJonesPA. Inhibition of DNA methylation by 5-aza-2′-deoxycytidine suppresses the growth of human tumor cell lines. Cancer Res1998; 58: 95–101.
16.
Schneider-StockRDiab-AssefMRohrbeckAFoltzer-JourdainneCBoltzeCHartigRSchonfeldPRoessnerAGali-MuhtasibH. 5-Aza-cytidine is a potent inhibitor of DNA methyltransferase 3 a and induces apoptosis in HCT-116 colon cancer cells via Gadd45- and p53-dependent mechanisms. J Pharmacol Exp Ther2005; 312: 525–36.
17.
FanYYZhangJBarhoumiRBurghardtRCTurnerNDLuptonJRChapkinRS. Antagonism of CD95 signaling blocks butyrate induction of apoptosis in young adult mouse colonic cells. Am J Physiol1999; 277: C310–9.
18.
KolarSSBarhoumiRCallawayESFanYYWangNLuptonJRChapkinRS. Synergy between docosahexaenoic acid and butyrate elicits p53-independent apoptosis via mitochondrial Ca(2+) accumulation in colonocytes. Am J Physiol Gastrointest Liver Physiol2007; 293: G935–43.
19.
CiavattaDJYangJPrestonGABadhwarAKXiaoHHewinsPNesterCMPendergraftWF3rdMagnusonTRJennetteJCFalkRJ. Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitis. J Clin Invest2010; 120: 3209–19.
20.
SuzukiMShigematsuHShivapurkarNReddyJMiyajimaKTakahashiTGazdarAFFrenkelEP. Methylation of apoptosis related genes in the pathogenesis and prognosis of prostate cancer. Cancer Lett2006; 242: 222–30.
21.
HervouetEValletteFMCartronPF. Impact of the DNA methyltransferases expression on the methylation status of apoptosis-associated genes in glioblastoma multiforme. Cell Death Dis2010; 1: e8–e8.
22.
TurkHFKolarSSFanYYCozbyCALuptonJRChapkinRS. Linoleic acid and butyrate synergize to increase Bcl-2 levels in colonocytes. Int J Cancer2011; 128: 63–71.
23.
YatesDRRehmanIAbbodMFMeuthMCrossSSLinkensDAHamdyFCCattoJW. Promoter hypermethylation identifies progression risk in bladder cancer. Clin Cancer Res2007; 13: 2046–53.
24.
HatadaIFukasawaMKimuraMMoritaSYamadaKYoshikawaTYamanakaSEndoCSakuradaASatoMKondoTHoriiAUshijimaTSasakiH. Genome-wide profiling of promoter methylation in human. Oncogene2006; 25: 3059–64.
25.
BellABellDWeberRSEl-NaggarAK. CpG island methylation profiling in human salivary gland adenoid cystic carcinoma. Cancer2011; 117: 2898–909.
26.
BabidgeWJButlerLMBurtonMACowledPA. Methylation of CpG sites in exon 2 of the bcl-2 gene occurs in colorectal carcinoma. Anticancer Res2001; 21: 2809–14.
27.
ChenZGuoKTohSYZhouZLiP. Mitochondria localization and dimerization are required for CIDE-B to induce apoptosis. J Biol Chem2000; 275: 22619–22.
28.
MartoriatiADoumontGAlcalayMBellefroidEPelicciPGMarineJ-C. dapk1, encoding an activator of a p19ARF-p53-mediated apoptotic checkpoint, is a transcription target of p53. Oncogene2004; 24: 1461–6.
29.
MahmoodZShuklaY. Death receptors: Targets for cancer therapy. Exp Cell Res2010; 316: 887–99.
30.
KolarSBarhoumiRJonesCKWesleyJLuptonJRFanYYChapkinRS. Interactive effects of fatty acid and butyrate-induced mitochondrial Ca(2+) loading and apoptosis in colonocytes. Cancer2011; 117: 5294–303.
31.
ForsbergECBresnickEH. Histone acetylation beyond promoters: Long-range acetylation patterns in the chromatin world. Bioessays2001; 23: 820–30.
KoboriABambaSImaedaHBanHTsujikawaTSaitoYFujiyamaYAndohA. Butyrate stimulates IL-32alpha expression in human intestinal epithelial cell lines. World J Gastroenterol2010; 16: 2355–61.
34.
O’ConnorLStrasserAO'ReillyLAHausmannGAdamsJMCorySHuangDCS. Bim: A novel member of the Bcl-2 family that promotes apoptosis. EMBO J1998; 17: 384–95.
35.
ShuLKhorTOLeeJHBoyanapalliSSHuangYWuTYSawCLCheungKLKongAN. Epigenetic CpG demethylation of the promoter and reactivation of the expression of Neurog1 by curcumin in prostate LNCaP cells. AAPS J2011; 13: 606–14.
36.
LykoFBrownR. DNA methyltransferase inhibitors and the development of epigenetic cancer therapies. J Natl Cancer Inst2005; 97: 1498–506.
37.
FangMZWangYAiNHouZSunYLuHWelshWYangCS. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res2003; 63: 7563–70.
38.
StilwellW. The role of polyunsaturated lipids in membrane raft function. Scand J Food Nutr2006; 50: 107–13.
39.
KaleANaphadeNSapkaleSKamarajuMPillaiAJoshiSMahadikS. Reduced folic acid, vitamin B12 and docosahexaenoic acid and increased homocysteine and cortisol in never-medicated schizophrenia patients: Implications for altered one-carbon metabolism. Psychiatry Res2010; 175: 47–53.
40.
DronamrajuSSCoxheadJMKellySBMathersJC. Differential antineoplastic effects of butyrate in cells with and without a functioning DNA mismatch repair. Nutr Cancer2010; 62: 105–15.
